VietaEGastóCOteroA. Differential features between bipolar I and bipolar II disorder. Compr Psychiatry. 1997;38(2):98–101.
2.
VietaE. Defining the bipolar spectrum and treating bipolar II disorder. J Clin Psychiatry. 2008;69(4):e12.
3.
RosaARBonnínCMVázquezGH. Functional impairment in bipolar II disorder: is it as disabling as bipolar I?J Affect Disord. 2010;127(1-3):71–76.
4.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychological Association; 1994.
5.
MalhiGOuthredTIrwinL. Bipolar II Disorder is a myth. Can J Psychiatry. 2019;64(8):531–536.
6.
VietaESuppesT. Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord. 2008;10(1 Pt 2):163–178.
7.
BarbutiMPacchiarottiIVietaE. Antidepressant-induced hypomania/mania in patients with major depression: evidence from the BRIDGE-II-MIX study. J Affect Disord. 2017;219:187–192.
8.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Publishing; 2013.
9.
FreedmanRLewisDAMichelsR. The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry. 2013;170(1):1–5.
VietaEPhillipsML. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr Bull. 2007;33(4):886–892.
12.
PopovicDReinaresMGoikoleaJM. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol. 2012;22(5):339–346.
13.
ColomFVietaESánchez-MorenoJ. Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis. J Affect Disord. 2009;112(1-3):30–35.
14.
BerkMVietaE. ICD-11 bipolar disorders. BMC Med. IN PRESS.
15.
PallaskorpiSSuominenKRosenströmT. Predominant polarity in bipolar I and II disorders: a five-year follow-up study. J Affect Disord. 2019;246:806–813.
16.
SentissiOPopovicDMoeglinC. Predominant polarity in bipolar disorder patients: the COPE bipolar sample. J Affect Disord. 2019;250:43–50.
17.
VietaE. Personalised medicine applied to mental health: precision psychiatry. Rev Psiquiatr Salud Ment. 2015;8(3):117–118.
VietaE. Antidepressants in bipolar I disorder: never as monotherapy. Am J Psychiatry. 2014;171(10):1023–1026.
20.
YathamLNKennedySHParikhSV. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170.
21.
ParkerG, ed. Bipolar II disorder: modeling, measuring and managing. 3rd ed. Cambridge (UK): Cambridge University Press; 2019.
22.
DaganiJSignoriniGNielssenO. Meta-analysis of the interval between the onset and management of bipolar disorder. Can J Psychiatry. 2017;62(4):247–258.
23.
VietaESalagreEGrandeI. Early intervention in bipolar disorder. Am J Psychiatry. 2018;175(5):411–426.
24.
MazzariniLColomFPacchiarottiI. Psychotic versus non-psychotic bipolar II disorder. J Affect Disord. 2010;126(1-2):55–60.
25.
ParkerGTavellaGMacqueenG. Revising Diagnostic and Statistical Manual of Mental Disorders, fifth edition, criteria for the bipolar disorders: phase I of the AREDOC project. Aust N Z J Psychiatry. 2018Oct 31 [Epub ahead of print]. doi:10.1177/0004867418808382
26.
StahlEABreenGForstnerAJ. Bipolar disorder working group of the psychiatric genomics consortium: genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51(5):793–803.
